BioInformant, Aug 2011, Pages: 130
Analysis of global grant activity, scientific publication rates, and patent applications reveal that research activity involving mesenchymalstemcells increased 58% year-over-year from 2008 to 2009
BioInformant, Nov 2011, Pages: 109
With recent advances in induced pluripotent stemcells (iPSC) creating excitement in stemcell research circles and U.S. President Obama expanding the number of human embryonic stemcell lines (h
Axis Research Mind, July 2010, Pages: 468
The ‘StemCells Market and Applications: (2009-2015)’ reviews the latest StemCells market trends with a perceptive to disclose the near-future growth prospects. An in-depth analysis across
Axis Research Mind, July 2010, Pages: 472
focuses on:
- Stemcell market trends in emerging markets
- Advancements in the technological space
- Demand of the market segments (by-region)
- Key growth areas and market size
- Competitors’ edge
BioPolaris, Feb 2010, Pages: 58
several other sources, including adult mesenchymal and hematopoetic stemcells, induced pluripotent stemcells, engineered stemcells, and embryonic stemcells.
The Cell and StemCell Therapies
Axis Research Mind, July 2010, Pages: 410
The ‘StemCells Market and Drug Discovery applications, 2009-2015’ reviews latest StemCells market trends with a perceptive to disclose the near-future growth prospects. An in-depth analysis across
Axis Research Mind, May 2011, Pages: 692
-2015. The major application use in stemcells market is classified into oncology, cardiology, and bone & cartilage. Among the applications areas, neurology is forecasts to exert highest support to the stemcells
BioInformant, Jan 2012, Pages: 113
.
This market report focuses on recent advances in NSC research applications, explores research priorities by market segment, highlights individual labs and end-users of neuronal stemcell research products, explores
Global Industry Analysts, Inc., Feb 2011, Pages: 566
and niche players such as AdvancedCell Technology, Inc., Athersys, Inc., BioE, Inc., Cryo-Cell International, Inc., Cytori Therapeutics, Inc., Edstrom Biosciences, Inc., Geron Corporation, International Stem
Elsevier Science and Technology, July 2009, Pages: 680
, practitioners and students that are embracing the latest advances in stemcells. Representing the combined effort of seven editors and more than 200 scholars and scientists whose pioneering work has defined our
Markets and Markets, Nov 2009, Pages: 229
For Allogenic Transplantation
5.2.4.2. Restraints & Opportunities
5.2.4.2.1. Low Number Of MesenchymalStemCells In Bone Marrow
5.2.4.3. Potential Applications Of Msc Therapy
5.3. Embryonic StemCells
5.3.1.
Business Insights, March 2006, Pages: 207
and fetal stemcell products.
- Discussion of opportunities arising out of advances in hematopoietic stemcell transplantation.
- Analysis of global regulatory issues which are dictating where and how
Axis Research Mind, March 2011, Pages: 531
STARGARDT’S MACULAR DYSTROPHY
EHSI: STEMCELLS COULD HELP HEART ATTACK VICTIMS
STEMCYTE, INC. RECEIVED TWO AWARDS TOTALING TO $488,950 FOR ADVANCED THERAPEUTIC APPLICATIONS OF UMBILICAL CORD BLOOD STEMCELLS
TriMark Publications, June 2010, Pages: 266
1.4.4.2 Neural StemCells
1.4.4.3 MesenchymalStemCells, Pancreatic Islet StemCells
1.5 Current State of StemCell Market
2. Biology of StemCells
2.1 Scope of this Chapter
2.2 Basic
Axis Research Mind, Nov 2011, Pages: 656
application areas discussed in the report are:
BY APPLICATIONSStemCells
Blood Products
Human (Tissue Sections, Brain, Liver, Eyes, Heart, Kidney and Others)
Veterinary
AdvancedApplications
- Genomics (DNA
Axis Research Mind, Nov 2011, Pages: 730
& technologies areas discussed in the report are:
BY APPLICATIONSStemCells
Blood Products
Human (Tissue Sections, Brain, Liver, Eyes, Heart, Kidney and Others)
Veterinary
AdvancedApplications
- Genomics (DNA
Axis Research Mind, Nov 2011, Pages: 730
.
The major applications & end-users areas discussed in the report are:
BY APPLICATIONSStemCells
Blood Products
Human (Tissue Sections, Brain, Liver, Eyes, Heart, Kidney and Others)
Veterinary
Advanced
Bizacumen Inc., Nov 2009, Pages: 286
Invitrogen Introduces Specific SFM for the MesenchymalStemCells 20
Invitrogen Unveils SequalPrep™ System 20
Invitrogen Introduces Animal Source-Free Substrate
Elsevier Science and Technology, Dec 2010, Pages: 1202
and instituions in StemCell Biology, Bioengineering, and Developmental Biology
- The first of its kind to offer an advanced understanding of the latest technologies in regenerative medicine
- New discoveries from
